Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 43 Leukemia, Myeloid, Acute 25 Recurrence 21 Lymphoma, Large B-Cell, Diffuse 12 Sarcoma 8 Neoplasms, Plasma Cell 5 Neoplasm Metastasis 5 Lymphoma 5 Glioblastoma 5 Ovarian Neoplasms 4 Neurofibrosarcoma 4 Neoplasms 4 Melanoma 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2

Interventions

Standard of Care 8 Hydroxychloroquine 4 BNT162 Vaccine 4 Practice Guidelines as Topic 3 Blood Specimen Collection 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 cilgavimab and tixagevimab drug combination 2 Specimen Handling 2 Sodium Chloride 2 CVnCoV COVID-19 vaccine 2 COVID-19 Vaccines 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 crexavibart 1 ciclesonide 1 bemcentinib 1 avdoralimab 1 acalabrutinib 1 XAV-19 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × COVID-19 × selinexor × Clear all

NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡